Dhru Deb, PhD

Cancer researcher by day, visual artist by night & New Yorker at heart

[Dhru Deb, PhD @CancerSciArtist]

A sneak peek of the amazing panel of speakers for @lcrf_org 's Nov 4 symposium on #Lungcancer Addressing Unmet Needs! Thanks to our industry sponsors @Merck & @Boehringer ! Can't wait to see who all registered and considering to register at https://t.co/eGK7sFHfW1 WE GOT YOU!

[Dhru Deb, PhD @CancerSciArtist]

The most inspiring thing about my job is to partner with amazing researchers and advocates who volunteer their stellar experience to help #lungcancer patients! @BrendonStilesMD @ODonnellLab_K @ipreeshagul & @ZieglerColleen thank you for your help with https://t.co/VATDyVw5QC

[Dhru Deb, PhD @CancerSciArtist]

Final round selection is happening to invest $2.5 million towards curing oncogene-driven lung cancer! Truly transformative research proposals and stellar discussion by scientific and research advocate reviewers! #LCSM #lungcancer #oncogene @lcrf_org @IASLC

[Lung Cancer Research Foundation @lcrf_org]

New funding opportunity: IASLC-LCRF Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven Lung Cancers, a $2.5 million, four-year award: https://t.co/aXNIvQ02oI

View the RFP and apply at https://t.co/76q4ezCiUr.

[Dhru Deb, PhD @CancerSciArtist]

What's the biggest unmet need for you? We want to hear from YOU. If you are a #lungcancer patient, caregiver, family member, physician, clinician, researcher, join us and share your voice at the @lcrf_org annual symposium on Nov 4! The esteemed panel will address unmet needs!

[Lung Cancer Research Foundation @lcrf_org]

#SaveTheDate for LCRF's 2024 Scientific Symposium: Monday, Nov. 4, 3-6pm ET. Our experts will lead a discussion on Lung Cancer: Addressing Unmet Needs. Registration is open for this virtual event: https://t.co/vMczM2VhVE

#LungCancer #LCAM

[Jill Feldman @jillfeldman4]

Very interesting finding for people with #EGFR #lungcancer that transforms to #SCLC! It appears that DLL3 was not present before transformation, but most patients showed DLL3 expression after it.

Currently, there isn't a good standard treatment, but further studies are needed to understand and determine if treatments targeting DLL3, such as tarlatamab, could be an option for patients after transformation.
#LCSM @EGFRResisters

[Dhru Deb, PhD @CancerSciArtist]

If your #LUNGCANCER research is related to EGFR, consider this summit! It's a great opportunity to meet other researchers and advocates to tackle this oncogene together! @jillfeldman4 @EGFRResisters

[EGFR Resisters Research Summit @EGFRSummit]

🚨⏳ FINAL CALL to submit your abstract for 2024 #EGFRSummit

DEADLINE TODAY ➡https://t.co/nWJtxivMQV

@jillfeldman4 @ZPiotrowskaMD @StephenVLiu @HelenaYu923 @maryjofidlerMD @christine_lovly @egfrresisters @CEC_onc #LCSM #EGFR

[Dhru Deb, PhD @CancerSciArtist]

@innovsophie Thanks, Sophie. I would love to know more about your advocacy work! I manage the research advocate program at LCRF and it's fascinating how advocacy helps to shape the unmet needs in lung cancer that research can address

[Dhru Deb, PhD @CancerSciArtist]

Our symposium for lung cancer patients & caregivers, discussing where research addresses unmet needs for immunotherapy, palliative care, telemedicine, KRAS, advocacy, small-cell and brain metastasis. Register & get ready with your questions for this amazing panel on Nov 4. #lcsm

[Lung Cancer Research Foundation @lcrf_org]

#SaveTheDate for LCRF's 2024 Scientific Symposium: Monday, Nov. 4, 3-6pm ET. Our experts will lead a discussion on Lung Cancer: Addressing Unmet Needs. Registration is open for this virtual event: https://t.co/vMczM2VhVE

#LungCancer #LCAM

[Dhru Deb, PhD @CancerSciArtist]

@BalazsHalmosMD @lcrf_org Thank you Dr. Halmos for attending the event!

[Dhru Deb, PhD @CancerSciArtist]

Drs. Politi & Vaishnavi at @lcrf_org 's evening on innovation!

[Dhru Deb, PhD @CancerSciArtist]

@lcrf_org Evening of Innovation Gala begins tonight! Raising fund to support #lungcancer research! #lcsm #metropolitanclub

[Dhru Deb, PhD @CancerSciArtist]

We are in round 2 of the selection process and what amazing proposals here! Great team science towards finding cure for oncogene-driven #lungcaner @lcrf_org @IASLC #lcsm

[Lung Cancer Research Foundation @lcrf_org]

New funding opportunity: IASLC-LCRF Team Science Research Grant on Advancing Therapies Towards Curing Oncogenic-Driven Lung Cancers, a $2.5 million, four-year award: https://t.co/aXNIvQ02oI

View the RFP and apply at https://t.co/76q4ezCiUr.

[Dhru Deb, PhD @CancerSciArtist]

Celebrating the launch of research grants on lung cancer HER2 alterations by @lcrf_org and @BayerPharma with @alitimumab and team! We did ideation to launch in 4 months! Excited to see some ground breaking research that incorporates patients' voice from the get-go!

[Lung Cancer Research Foundation @lcrf_org]

LCRF is pleased to announce its collaboration with Bayer Pharmaceuticals to fund two research grants focused on innovative strategies to advance understanding and management of #LungCancer with HER2 mutations and/or other HER2 alterations. Find out more at https://t.co/4daMqHMS3e

[JessicaJLinMD @JessicaJLinMD]

Pleased to share an updated efficacy, safety, and biomarker analysis of Larotrectinib in TRK fusion+ NSCLC, presented at the #WCLC24 today
[1/6]

[Dhru Deb, PhD @CancerSciArtist]

Last day of #WCLC24 : learnt so much, hugged so many friends, got inspired by the research and advocacy from all over the world and felt very hopeful that we all are in this together! #lcsm #lungcancer

[Dhru Deb, PhD @CancerSciArtist]

Huge thanks to all members of the @lcrf_org family, partners and collaborators for making our scientific board meeting such a blast last evening! Special thanks to Kelsey Hecker @IASLC in helping with our in person meeting during #wclc24 Excited for the new directions in research

[Dhru Deb, PhD @CancerSciArtist]

As a scientist by training for me this was a crash course on patient advocacy! So exciting to see advocates from all over the world!

[Lung Cancer Research Foundation @lcrf_org]

LCRF's Dhru Deb @CancerSciArtist with fellow patient advocates at today's Global Lung Cancer Coalition @globalungcancer meeting! #patientvoices #lungcancerresearch

[Dhru Deb, PhD @CancerSciArtist]

Warm up to #WCLC24 began yesterday for me by meeting with ~40 #lungcancer #patientadvocates from around the world at the GLCC meeting reception! Looking forward to seeing all the members of @lcrf_org family over the next couple of days!

[Dhru Deb, PhD @CancerSciArtist]

"Liberating HER": Excited to see this partnership going from ideation at #aacr24 to announcement at #wclc24 in 5 months! My "research advocate" friends, this is such a promising step for #HER2 #lungcancer patients! #lcsm

[Lung Cancer Research Foundation @lcrf_org]

LCRF is pleased to announce its collaboration with Bayer Pharmaceuticals to fund two research grants focused on innovative strategies to advance understanding and management of #LungCancer with HER2 mutations and/or other HER2 alterations. Find out more at https://t.co/4daMqHMS3e

[Dhru Deb, PhD @CancerSciArtist]

@Yvonne_Diaz_ @lcrf_org Thank you, Yvonne! Let's also celebrate the central role research advocates like yourself play in helping to formulate and select the best and the brightest research for lung cancer!